EU and US could reach trade deal this weekend - Reuters
Investing.com - Baird raised its price target on Intuitive Surgical (NASDAQ:ISRG) to $600.00 from $590.00 on Wednesday, while maintaining an Outperform rating on the surgical robotics company. The new target sits within the analyst range of $350-$675, with InvestingPro data showing the stock currently trading at $511.
The price target increase follows Intuitive Surgical’s strong quarterly performance, which showed accelerating revenue and EPS growth of 21% and 23% respectively across all business segments, according to Baird. This aligns with the company’s impressive 19% year-over-year revenue growth and 67% gross profit margin, as reported by InvestingPro.
The research firm noted that Intuitive Surgical delivered its highest operating margin in the last 15 quarters, despite ongoing concerns about remanufactured instruments and accessories.
Baird cited several positive factors supporting its outlook, including the full launch of the company’s dV5 surgical system and decreasing headwinds from China tariffs, which aligned with the firm’s expectations.
These developments prompted Baird to raise its fiscal year 2025 and 2026 EPS estimates by approximately 3% and 4%, representing year-over-year growth of 12% and 16% respectively.
In other recent news, Intuitive Surgical Inc . reported strong financial results for the second quarter of 2025, exceeding analysts’ expectations. The company achieved earnings per share of $2.19, surpassing the forecasted $1.93, marking a 13.47% positive surprise. Revenue for the quarter reached $2.44 billion, beating the anticipated $2.35 billion. These results highlight Intuitive Surgical’s robust performance in the recent period. Despite the favorable earnings report, Intuitive Surgical’s stock experienced a slight decline in regular trading, though it saw a minor increase in after-hours trading. Analysts from various firms have taken note of these developments, with some adjusting their outlook on the stock. Investors are likely to keep a close watch on the company’s next moves following these recent updates.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.